FDA approves first new non-opioid pain pill in decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
Medscape2d
Science Behind FDA-Approved Genetic Test for OUD Questioned
A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Medical News Today4d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Next-generation tau radiotracers outperform FDA-approved imaging agents in detecting Alzheimer's disease
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
rheumatologyadvisor3d
Websites Selling Compounded GLP-1 RAs Often Misinform Consumers
Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.